CLINICAL_TRIALS
trial_result
· 2019-12-09
Clinical Trial Update: A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study [Phase 2]
Summary
Phase 2 off-drug extension study evaluating sarcopenic elderly after completion of a 6-month core study; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Sarcopenia | Phase 2 | Status: COMPLETED | Results posted: 2019-12-09